---
title: FidoCure blog | Abigail Christman Hull, CVT, VTS(ECC)
description: Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates.
---

[![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/)

- [Veterinarians](https://fidocure.com/for-veterinarians/) 
    - [Portal Login](https://dvm.fidocure.com/)
    - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
    - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
    - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)

# FidoCure Veterinary Team Blog

### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors

Select Category Case Studies Press Vet Webinars

This is a search field with an auto-suggest feature attached.

- There are no suggestions because the search field is empty.

Posts by:

## Abigail Christman Hull, CVT, VTS(ECC)

![](https://blog.fidocure.com/hubfs/pixelle.jpg)

### [Adrenocortical Carcinoma Case Study: Pixelle](https://blog.fidocure.com/fidocure-blog/adrenocortical-carcinoma-case-study-pixelle)

##### **History and Initial Treatment**

Pixelle, a 13 year old Shih Tzu, started her long cancer journey in June of 2020 when she was diagnosed with a left-sided adrenal mass after undergoing a thorough workup for vomiting, polyuria/polydipsia, and intermittent urinary incontinence. A pheochromocytoma was ruled out as a low-dose dexamethasone suppression test was consistent with Cushing’s Disease (cortisol secreting tumor). 

[Read More](https://blog.fidocure.com/fidocure-blog/adrenocortical-carcinoma-case-study-pixelle)

![](https://blog.fidocure.com/hubfs/Maggie%20Donahue%20photo%20(1)-1.jpg)

### [Case Study: Malignant Oral Melanoma](https://blog.fidocure.com/fidocure-blog/malignant-oral-melanoma)

##### **History and Treatment Planning**

Maggie, a friendly and rambunctious 12 year old, spayed female pug, was diagnosed with malignant oral melanoma in March 2022 by her primary care veterinarian. The mass was located on her upper left dental arcade. Her veterinarian surgically debulked approximately 80% of the mass. Unfortunately, Maggie experienced rapid local recurrence within a month of the surgery, involving the maxilla, and the adjacent mandibular lymph node.

[Read More](https://blog.fidocure.com/fidocure-blog/malignant-oral-melanoma)

![](https://blog.fidocure.com/hubfs/iStock-500430393.jpg)

### [Undifferentiated Oral Malignancy Case Study](https://blog.fidocure.com/fidocure-blog/undifferentiated-oral-malignancy-case-study)

##### **History and Treatment Planning**

A 12 year old, neutered male Golden Retriever, underwent a dental prophylaxis procedure performed by his primary care veterinarian in June of 2021. At that time, no suspicious lesions or growths were noted. In October 2021, his family discovered a marble-sized growth in his mouth along the gum line of his left maxilla. The mass was visible from the outside of his mouth, and seemed to cause him irritation. At the time, it was bloody (perhaps from self trauma/stick chewing). Antibiotics were prescribed, but the dog quickly developed worsening clinic signs (nasal discharge, swelling, lethargy). 

[Read More](https://blog.fidocure.com/fidocure-blog/undifferentiated-oral-malignancy-case-study)

![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg)

- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)

- <https://www.instagram.com/fidocure/>
- <https://twitter.com/fidocure>
- <https://www.facebook.com/FidoCure/>
- <https://www.pinterest.com/fidocure/>

**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy. 

© Copyright 2018-2026 One Health Company, All rights reserved